Radical laparoscopic salvage prostatectomy: Medium-term functional and oncological results

Journal of Endourology

Volumn 23, Issue 8, 2009, Pages 1301-1305

  Nuñez Mora, Carlos ^a   García Mediero, Jose M ^a   Cabrera Castillo, Pedro M ^a  

^a MD ANDERSON CANCER CENTER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; GLEASON SCORE; HEMATURIA; HUMAN; INCONTINENCE; LAPAROSCOPIC SURGERY; LYMPH NODE METASTASIS; LYMPHOCELE; MALE; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECURRENT DISEASE; SPHINCTER; SURGICAL TECHNIQUE; TRANSFUSION; TREATMENT DURATION;

AGED; FOLLOW-UP STUDIES; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY;

EID: 68949087999     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2009.0019     Document Type: Article

References (27)

1. Mettlin CJ, Murphy GP, McDonald CJ, Menck HR. The National Cancer Data Base report on increased use of bra- chytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer 1999;86:1877-1882.
2. Stephenson RA. Prostate cancer trends in the era of prostate- specific antigen. An update of incidence, mortality and clinical factors from the SEER database. Urol Clin North Am 2002;29:173-181.
3. Chen BT, Wood DP, Jr. Salvage prostatectomy in patients who have failed radiation therapy or cryotherapy as primary treatment for prostate cancer. Urology 2003;62:69-78.
4. Kuban DA, el-Mahdi AM, Schellhammer PF. Prostate- specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 1995; 32:307-316.
5. Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis. JAMA 1999;281:1598-1604.
6. D'Amico AV, Cote K, Loffredo M, Renshaw AA, Schultz D. Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer. J Clin Oncol 2002;20:4567-4573.
7. Kupelian PA, Buchsbaum JC, Patel C, Elshaikh M, Reddy CA, Zippe C, Klein EA. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. Int J Radiat Oncol Biol Phys 2002; 52:704-711.
8. Sanderson KM, Penson DF, Cai J, Groshen S, Stein JP, Lieskovsky G, Skinner DG. Salvage radical prostatectomy: Quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol 2006;176:2025-2032.
9. Leibovici D, Spiess PE, Heller L, Rodriguez-Bigas M, Chang G, Pisters LL. Salvage surgery for locally recurrent prostate cancer after radiation therapy: Tricks of the trade. Urol Oncol 2008;26:9-16.
10. Vallancien G, Gupta R, Cathelineau X, Baumert H, Rozet F. Initial results of salvage laparoscopic radical prostatectomy after radiation failure. J Urol 2003;170:1838-1840.
11. Stolzenburg JU, Bynens B, Do M, Rabenalt R, Katsakiori PF, Liatsikos E. Salvage laparoscopic extraperitoneal radical prostatectomy after failed high-intensity focused ultrasound and radiotherapy for localized prostate cancer. Urology 2007;70:956-960.
12. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus Statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1035-1041.
13. Darras J, Joniau S, van Poppel H. Salvage radical prostatectomy for radiorecurrent prostate cancer: Indications and results. EJSO 2006;32:964-969.
14. Heidenreich A, Ohlmann C, Ozgur E, Engelmann U. Radi- kale Salvageprostatektomie bei locales Prostatakarzinomre- zidiv nach Strahlentherapie. Funktionelle und onkologische Ergebnisse. Urologe 2006;45:474-481. (In German.)
15. Stephenson AJ, Easthan JA. Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. J Clin Oncol 2005;23:8198-8203.
16. Hautmann RE. Salvage-radikale Prostatektomie. Urologe 2006;45:1260-1265. (In German.)
17. Neerhut GJ, Wheeler T, Cantini M, Scardino PT. Salvage radical prostatectomy for radiorecurrent adenocarcinoma for the prostate. J Urol 1988:140:544-549.
18. Rogers E, Ohori M, Kassabian VS, Wheeler TM, Scardino PT. Salvage radical prostatectomy: Outcome measured by serum prostate specific antigen levels. J Urol 1995;153:104-110.
19. Rainwater LM, Zincke H. Radical prostatectomy after radiation therapy for cancer of the prostate: Feasibility and prognosis. J Urol 1988;140:1455-1459.
20. Zincke H. Radical prostatectomy and exenterative procedures for local failure after radiotherapy with curative intent: Comparison of outcomes. J Urol 1992;147:894-899.
21. Pontes JE, Montie J, Klein E, Huben R. Salvage surgery for radiation failure in prostate cancer. Cancer 1993;71:976-980.
22. Zagars GK, Pollack A, von Eschenbach AC. Prostate cancer and radiation therapy: The message conveyed by serum prostate-specific antigen. Int J Radiat Oncol Biol Phys 1995; 33:23-35.
23. Amling CL, Lerner SE, Martin SK, et al. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer. J Urol 1999;161:857-862.
24. Link P, Freiha FS. Radical prostatectomy after definitive radiation therapy for prostate cancer. Urology 1991;37:189-192.
25. Bianco FJ Jr., Scardino PT, Stephenson AJ, DiBlasio CJ, Fearn PA, Eastham JA. Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:448-453.
26. Stephenson AJ, Scardino PT, Bianco FJ, Jr., DiBlasio CJ, Fearn PA, Eastham JA. Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 2004;172:2239-2243.
27. Ward JF, Sebo TJ, Blute ML, Zincke H. Salvage surgery for radiorecurrent prostate cancer: Contemporary outcomes. J Urol 2005;173:1156-1160.